Limited Access
Sign in or upgrade to access the strengths identified for this brand.
AI Brand Visibility
The Open Benchmark of AI Brand Recommendations.
AI is no longer just answering. It is shaping brand preference.
Quelles sont les recommandations des IA concernant le GLP-1 et la gestion du poids aux États-Unis ?
Les consommateurs et professionnels de la santé aux États-Unis recherchent fréquemment des informations sur les traitements GLP-1 et les stratégies plus larges de gestion du poids.
Huit questions suivies explorent les réponses de l'IA concernant les conseils médicaux sur l'efficacité, la sécurité, les effets secondaires et les alternatives des GLP-1 pour la perte de poids.
Alors que les consommateurs s'attendent à des discussions autour des médicaments GLP-1, des interventions sur le mode de vie et des plans diététiques pour la gestion du poids, la concordance entre les recommandations de l'IA et les perspectives médicales largement comprises sur ces options est ce que le benchmark révèle. Mis à jour quotidiennement.
Filters
Countries
1USA 8
Filters
1 📅 03 Oct 2026 to 09 Oct 2026
Questions
88 / 8 selected
What do doctors say about GLP-1 medications for weight loss?
How do healthcare professionals explain how GLP-1 treatments work for managing weight?
What are the main benefits and risks of GLP-1 medications, according to doctors?
Who are GLP-1 weight loss treatments really appropriate for, from a medical point of view?
What side effects do doctors warn patients about when starting GLP-1 treatments?
How do doctors manage digestive side effects like nausea or constipation with GLP-1 medications?
Are there safer or more appropriate alternatives to GLP-1 treatments for weight management?
What do doctors recommend for people looking to manage weight without prescription injections?
Wegovy
USA03-10-2026 to 09-10-2026
General Ranking
1
5 analyzed brands
Total Mentions
37
▲+27.6%vs previous period
Share of Voice
9.25%
▲+1.54 ptsvs previous period
Label
👑Category Owner
AI visibility Score
100
▲+4vs previous period
Wegovy Performance Summary
Overview
- La visibilité globale de Wegovy est excellente, atteignant un score de 100/100.
- Wegovy maintient une position de leader dans sa catégorie avec un score de 100.
- La marque a connu une augmentation notable de sa visibilité au cours des 7 derniers jours.
- Le produit principal visible est Wegovy Semaglutide, mentionné 8 fois.
- La période d'analyse s'étend du 3 octobre 2026 au 9 octobre 2026.
Strengths
Look Out For
Limited Access
Sign in or upgrade to access the signals that require attention.
Brand Mentions Over Time - How is my brand presence in AI evolving?
This chart shows how often your brand is mentioned by LLMs over time.
Brand Share of Mentions - What share of AI visibility do we own versus competitors?
Shows how mentions are distributed across brands in LLMs' responses.
AI Visibility Trend - Is my Brand AI visibility score improving over time?
The higher the score, the more your brand appears and performs in LLM responses.
Ranking Evolution - Is my brand gaining or losing positions?
This chart shows how your average position evolves in global ranking.
Top Performing Products - Which products contribute the most to our visibility?
Compare product visibility across your portfolio in LLM's responses.
Semaglutide: 8 (2.7%)
Semaglutide Injection: 5 (1.7%)
Pill: 2 (0.7%)
Hd Semaglutide High-dose Injection: 1 (0.3%)
Wegovy: 1 (0.3%)
(semaglutide): 1 (0.3%)
Semaglutide 2.4 Mg Injection: 1 (0.3%)
Oral Wegovy: 1 (0.3%)
Semaglutide 2.4 Mg Weekly: 1 (0.3%)
Others: 278 (93.0%)
Top Recommended Products - Which of my products are most frequently recommended by LLM models?
Compare how often each product appears among the top LLM recommendations.
Brand Coverage By Theme - Which key strategic topics drive my brand AI visibility?
Compare your visibility across your key strategic themes
No themes defined for Wegovy.